2. Gene
  3. Rpe - ribulose-5-phosphate-3-epimerase Gene

Rpe - ribulose-5-phosphate-3-epimerase Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Mus musculus

Also known as 2810429B02Rik; 5730518J08Rik

Gene ID: 66646 | Gene type: protein coding

About Rpe

Summary

Predicted to enable several functions, including monosaccharide binding activity; protein homodimerization activity; and ribulose-phosphate 3-epimerase activity. Predicted to be involved in cellular carbohydrate metabolic process; pentose catabolic process; and pentose-phosphate shunt, non-oxidative branch. Predicted to act upstream of or within carbohydrate metabolic process. Predicted to be located in intracellular membrane-bounded organelle. Predicted to be active in cytosol. Is expressed in several structures, including alimentary system; central nervous system; genitourinary system; integumental system; and nose. Orthologous to several human genes including RPE (ribulose-5-phosphate-3-epimerase). [provided by Alliance of Genome Resources, Apr 2022]

Rpe Products(4)

mRNA Protein Name
NM_001310642.1 NP_001297571.1 ribulose-phosphate 3-epimerase isoform 1
NM_001310643.1 NP_001297572.1 ribulose-phosphate 3-epimerase isoform 3
NM_001310644.1 NP_001297573.1 ribulose-phosphate 3-epimerase isoform 4
NM_025683.3 NP_079959.2 ribulose-phosphate 3-epimerase isoform 2
Protein Preferred Names Protein Names

ribulose-phosphate 3-epimerase

ribulose-5-phosphate-epimerase

Recombinant Rpe Proteins

Cat. No. Product Name Accession Purity
HY-P73673 RPE Protein, Mouse (HEK293, His) Q8VEE0 (M1-R228) ≥95%

Related Agents

Approval
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-148457 Avacincaptad pegol Inhibitor / Unkown
Clinical Phase
Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-19720A Emixustat hydrochloride 99.59% Phase 3
HY-19720 Emixustat Inhibitor 98.00% Phase 3
HY-101019 Ossirene Inhibitor ≥98.0% Phase 2
HY-125639 (rac)-AR-13503 Inhibitor / Phase 1
Pre-clinical Phase
Bioactive Molecules (18)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-134928A Pyridinium bisretinoid A2E TFA ≥90.0% Unkown
HY-N0428 Obacunone Inducer 99.75% Unkown
HY-D0988 R-PE (R-Phycoerythrin) / Unkown
HY-101293 VU0359595 Inhibitor 99.65% Unkown
HY-D1742 DRAQ5 Chemical / Unkown
HY-12462 WS3 98.00% Unkown
HY-22024 5-Hydroxyflavone 99.83% Unkown
HY-149325 RPE65-IN-1 ≥98.0% Unkown
HY-134928 Pyridinium bisretinoid A2E / Unkown
HY-163684 Zoracopan Inhibitor 99.85% Unkown
HY-P5169A LVGRQLEEFL (mouse) (TFA) 98.20% Unkown
HY-151872 HDAC-IN-48 / Unkown
HY-162904 BPU17 / Unkown
HY-N11499 Myricetin 3-O-α-L-arabinopyranoside Inhibitor / Unkown
HY-P4253 Arginyl-Glutamine Inhibitor / Unkown
HY-P5169 LVGRQLEEFL (mouse) / Unkown
HY-RS12150 RPE Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS12151 RPE65 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Rpe NCBI NCBI:6120
Rattus norvegicus Rpe NCBI NCBI:501157
Macaca mulatta Rpe NCBI NCBI:711322